SCHEMBL429325

SCHEMBL429325

c1ccc(-c2ccccc2-c2cccc3c2oc2c(-c4ccccc4-c4ccccc4-c4cccc5c4oc4c(-c6ccccc6-c6ccccc6)cccc45)cccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 6/20 0.49
ALOX5 P09917 2/20 0.42
ALDH1A1 P00352 7/20 0.41
HSD17B10 Q99714 4/20 0.41
PIK3CD O00329 3/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CB P42338 3/20 0.41
PIK3CG P48736 3/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
BRD4 O60885 2/20 0.41
BRD2 P25440 2/20 0.41
BRD3 Q15059 2/20 0.41
TP53 P04637 2/20 0.41
TSHR P16473 2/20 0.41
NFKB1 P19838 2/20 0.41
PDE2A O00408 1/20 0.41
PIK3C2A O00443 1/20 0.41
PIK3R2 O00459 1/20 0.41
PIK3C2B O00750 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16182124 0.98 PRKDC (0.48) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL430105 0.96 PRKDC (0.46) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL429313 0.92 ALOX5 (0.46) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL11713826 0.91 PRKDC (0.47) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL16182153 0.88 ALOX5 (0.57) PRKDCALOX5PIK3CDPIK3CBSMN1; SMN2
SCHEMBL16182148 0.88 ALOX5 (0.57) PRKDCALOX5PIK3CDPIK3CBSMN1; SMN2
SCHEMBL16182136 0.88 ALOX5 (0.57) PRKDCALOX5PIK3CDPIK3CBSMN1; SMN2
SCHEMBL21157813 0.88 PRKDC (0.45) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL21157074 0.88 PRKDC (0.45) PRKDCALOX5ALDH1A1HSD17B10PIK3CD
SCHEMBL22151549 0.87 ALOX5 (0.49) PRKDCALOX5ALDH1A1HSD17B10PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9406893-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-9406893-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-20140299861-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2014-10-09 US disclosed
US-20140299861-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2014-10-09 US disclosed
US-8790794-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-29 US disclosed
US-8790794-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-29 US disclosed
US-20120061651-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-15 US disclosed
US-20120061651-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061651-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device CYP2J2, CYP1A1, CRY1 PRKDC 4868/4885ALOX5 2991/4885ALDH1A1 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.